SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-016980
Filing Date
2018-07-19
Accepted
2018-07-19 06:59:47
Documents
4
Period of Report
2018-07-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ovid-8k_20180718.htm 8-K 26615
2 EX-99.1 ovid-ex991_6.htm EX-99.1 48930
3 GRAPHIC ghw505axnfxw000002.jpg GRAPHIC 2310
4 GRAPHIC ghw505axnfxw000001.jpg GRAPHIC 43101
  Complete submission text file 0001564590-18-016980.txt   139455
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 18959526
SIC: 2834 Pharmaceutical Preparations